Display options
Share it on

Cancer Microenviron. 2015 Dec;8(3):167-76. doi: 10.1007/s12307-014-0152-8. Epub 2014 Sep 07.

The Role of Mast Cells in Molding the Tumor Microenvironment.

Cancer microenvironment : official journal of the International Cancer Microenvironment Society

A Rigoni, M P Colombo, C Pucillo

Affiliations

  1. Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, via Amadeo 42, 20133, Milan, Italy.
  2. Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, via Amadeo 42, 20133, Milan, Italy. [email protected].
  3. Department of Medical and Biological Sciences, University of Udine, 33100, Udine, Italy.

PMID: 25194694 PMCID: PMC4715001 DOI: 10.1007/s12307-014-0152-8

Abstract

Mast cells (MCs) are granulocytic immune cells that reside in tissues exposed to the external environment. MCs are best known for their activity in allergic reactions, but they have been involved in different physiological and pathological conditions. In particular, MC infiltration has been shown in several types of human tumors and in animal cancer models. Nevertheless, the role of MCs in the tumor microenvironment is still debated because they have been associated either to good or poor prognosis depending on tumor type and tissue localization. This dichotomous role relies on MC capacity to secrete a broad spectrum of molecules with modulatory functions, which may condition the final tumor outcome also promoting angiogenesis and tissue remodeling. In this review, we analyze the multifaceted role of mast cell in tumor progression and inhibition considering their ability to interact with: i) immune cells, ii) tumor cells and iii) the extracellular matrix. Eventually, the current MC targeting strategies to treat cancer patients are discussed. Deciphering the actual role of MCs in tumor onset and progression is crucial to identify MC-targeted treatments aimed at killing cancer cells or at making the tumor vulnerable to selected anti-cancer drugs.

Keywords: Cancer; Extracellular matrix; Immune responses; Immunosuppression; Mast cell

References

  1. Gut. 1999 Dec;45(6):856-63 - PubMed
  2. Semin Immunopathol. 2013 Nov;35(6):671-5 - PubMed
  3. Immunol Rev. 2007 Jun;217:304-28 - PubMed
  4. Trends Immunol. 2004 May;25(5):235-41 - PubMed
  5. Biomaterials. 2007 Jan;28(3):371-82 - PubMed
  6. Oncology. 2013;85(2):111-6 - PubMed
  7. Biochim Biophys Acta. 2012 Jan;1822(1):9-13 - PubMed
  8. J Immunol. 2004 Jan 15;172(2):1227-36 - PubMed
  9. J Immunol. 2007 Jun 15;178(12):8081-9 - PubMed
  10. Cancer Res. 2011 Sep 15;71(18):5987-97 - PubMed
  11. Am J Pathol. 2005 Sep;167(3):835-48 - PubMed
  12. Annu Rev Pharmacol Toxicol. 2000;40:519-61 - PubMed
  13. Oncogene. 2011 Feb 17;30(7):757-69 - PubMed
  14. Nat Rev Clin Oncol. 2011 Mar;8(3):161-70 - PubMed
  15. J Gastrointest Cancer. 2014 Mar;45(1):48-53 - PubMed
  16. Trends Immunol. 2010 Mar;31(3):97-102 - PubMed
  17. J Immunol. 1998 Sep 1;161(5):2586-93 - PubMed
  18. Blood. 2009 Sep 24;114(13):2639-48 - PubMed
  19. Am J Pathol. 2010 Aug;177(2):792-802 - PubMed
  20. Cancer Res. 2004 Jul 15;64(14):4707-10 - PubMed
  21. Blood. 1992 Feb 15;79(4):958-63 - PubMed
  22. Nature. 2013 Sep 19;501(7467):346-54 - PubMed
  23. J Allergy Clin Immunol. 2006 Jun;117(6):1214-25; quiz 1226 - PubMed
  24. Lab Invest. 2012 Oct;92(10):1472-82 - PubMed
  25. Clin Cancer Res. 2010 Apr 15;16(8):2257-65 - PubMed
  26. Genes Dev. 1999 Jun 1;13(11):1382-97 - PubMed
  27. J Allergy Clin Immunol. 2014 Sep;134(3):530-44 - PubMed
  28. J Clin Oncol. 2005 Dec 10;23(35):8959-67 - PubMed
  29. J Immunol. 2009 May 15;182(10):6562-8 - PubMed
  30. Immunol Rev. 2007 Jun;217:141-54 - PubMed
  31. J Allergy Clin Immunol. 2004 Nov;114(5 Suppl):S135-8 - PubMed
  32. J Cutan Pathol. 1998 Jan;25(1):11-5 - PubMed
  33. Clin Cancer Res. 2013 May 1;19(9):2342-54 - PubMed
  34. Cancer Res. 2009 Jul 1;69(13):5490-7 - PubMed
  35. Cancer Immunol Immunother. 2013 Oct;62(10):1575-85 - PubMed
  36. Surgery. 2011 Apr;149(4):576-84 - PubMed
  37. Cancer. 2000 Jun 15;88(12):2686-92 - PubMed
  38. Nature. 2001 Sep 27;413(6854):420-5 - PubMed
  39. Blood. 2014 Mar 20;123(12):1836-49 - PubMed
  40. Nat Immunol. 2008 Nov;9(11):1215-23 - PubMed
  41. J Clin Pathol. 2004 Jun;57(6):630-6 - PubMed
  42. Adv Exp Med Biol. 2011;716:186-211 - PubMed
  43. J Immunol. 2001 Jun 1;166(11):6972-81 - PubMed
  44. Breast Cancer Res Treat. 2008 Jan;107(2):249-57 - PubMed
  45. Hum Reprod. 1997 Feb;12(2):368-72 - PubMed
  46. PLoS One. 2010 Jan 27;5(1):e8922 - PubMed
  47. Br J Haematol. 2007 Jul;138(1):68-71 - PubMed
  48. Allergy. 2013 Sep;68(9):1093-101 - PubMed
  49. Recent Pat Anticancer Drug Discov. 2012 Jan;7(1):74-101 - PubMed
  50. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3439-43 - PubMed
  51. Cell. 1990 Oct 5;63(1):235-43 - PubMed
  52. Dis Colon Rectum. 1995 Mar;38(3):290-3 - PubMed
  53. Immunity. 2012 Jul 27;37(1):25-33 - PubMed
  54. BMC Cancer. 2007 Aug 29;7:165 - PubMed
  55. Lung Cancer. 2003 Dec;42(3):255-61 - PubMed
  56. Cell. 2008 Oct 31;135(3):437-48 - PubMed
  57. Eur J Cancer. 2012 Sep;48(13):1977-87 - PubMed
  58. Exp Mol Pathol. 2014 Apr;96(2):230-4 - PubMed
  59. Adv Exp Med Biol. 2011;716:143-59 - PubMed
  60. Gastroenterology. 2011 Jul;141(1):237-48, 248.e1 - PubMed
  61. Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19977-82 - PubMed
  62. J Immunol. 2012 Jul 1;189(1):120-7 - PubMed
  63. Semin Immunopathol. 2009 Jul;31(2):185-205 - PubMed
  64. Environ Sci Technol. 2007 May 15;41(10):3775-80 - PubMed
  65. Br J Pharmacol. 2010 Oct;161(4):755-67 - PubMed
  66. Breast Cancer Res Treat. 2004 Jan;83(1):33-42 - PubMed
  67. Am J Pathol. 2010 Aug;177(2):1031-41 - PubMed
  68. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S73-80 - PubMed
  69. J Pharmacol Sci. 2005 Aug;98(4):450-8 - PubMed
  70. Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9990-5 - PubMed
  71. Immunol Rev. 2007 Jun;217:65-78 - PubMed
  72. J Cell Mol Med. 2013 Aug;17(8):1025-37 - PubMed
  73. Cancer Res. 2009 Jul 15;69(14):5619-22 - PubMed
  74. Dev Biol. 2010 Jan 1;337(1):124-33 - PubMed
  75. Methods Mol Biol. 2001;151:149-79 - PubMed
  76. Cancer Res. 2011 Mar 1;71(5):1627-36 - PubMed
  77. PLoS One. 2010 Aug 17;5(8):e12220 - PubMed
  78. Nat Med. 2007 Oct;13(10):1211-8 - PubMed
  79. Cancer Res. 2012 Feb 15;72(4):831-5 - PubMed
  80. Blood. 2008 Aug 15;112(4):1269-79 - PubMed
  81. Cancer Prev Res (Phila). 2010 Oct;3(10):1314-33 - PubMed
  82. Cancer Res. 2013 Oct 1;73(19):5905-13 - PubMed
  83. J Immunol. 2012 Jul 15;189(2):511-5 - PubMed
  84. Br J Haematol. 2002 Oct;119(1):122-4 - PubMed
  85. Eur J Clin Invest. 2003 May;33(5):420-5 - PubMed
  86. Trends Pharmacol Sci. 2013 Jan;34(1):33-58 - PubMed
  87. Am J Transplant. 2009 Oct;9(10):2270-80 - PubMed
  88. Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:24-30 - PubMed
  89. Immunity. 2008 Nov 14;29(5):771-81 - PubMed
  90. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4464-8 - PubMed
  91. Eur Respir J. 2000 Jun;15(6):1087-93 - PubMed
  92. Front Immunol. 2012 Aug 02;3:238 - PubMed
  93. J Gastroenterol Hepatol. 2009 Jul;24(7):1265-75 - PubMed
  94. Blood. 2012 Sep 6;120(10):2042-54 - PubMed
  95. Cancer Cell Int. 2006 Dec 19;6:28 - PubMed

Publication Types